Intuitive Surgical, Inc. $ISRG Shares Sold by Quintet Private Bank Europe S.A.

Quintet Private Bank Europe S.A. decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 88.6% during the 3rd quarter, HoldingsChannel reports. The fund owned 3,862 shares of the medical equipment provider’s stock after selling 29,959 shares during the quarter. Quintet Private Bank Europe S.A.’s holdings in Intuitive Surgical were worth $1,570,000 at the end of the most recent quarter.

A number of other hedge funds have also recently modified their holdings of the company. Alteri Wealth LLC boosted its holdings in Intuitive Surgical by 5.0% in the fourth quarter. Alteri Wealth LLC now owns 483 shares of the medical equipment provider’s stock worth $274,000 after acquiring an additional 23 shares in the last quarter. Connecticut Wealth Management LLC raised its position in shares of Intuitive Surgical by 1.8% in the 4th quarter. Connecticut Wealth Management LLC now owns 1,308 shares of the medical equipment provider’s stock worth $741,000 after purchasing an additional 23 shares during the last quarter. 3Chopt Investment Partners LLC boosted its stake in Intuitive Surgical by 5.2% in the 1st quarter. 3Chopt Investment Partners LLC now owns 462 shares of the medical equipment provider’s stock worth $213,000 after purchasing an additional 23 shares in the last quarter. Vermillion Wealth Management Inc. increased its stake in Intuitive Surgical by 58.1% during the 1st quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock valued at $31,000 after purchasing an additional 25 shares in the last quarter. Finally, W.G. Shaheen & Associates DBA Whitney & Co raised its holdings in Intuitive Surgical by 1.0% in the first quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock worth $1,172,000 after buying an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Barclays initiated coverage with an Overweight rating and later upgraded ISRG to Strong Buy. The firm’s bullish stance provides a positive catalyst and suggests confidence in Intuitive Surgical’s market position despite a softer medical-device environment. Barclays initiates coverage of Intuitive Surgical at Overweight Intuitive Surgical upgraded at Barclays
• Positive Sentiment: Wall Street analysts remain optimistic. Coverage highlights expectations for year-over-year revenue and earnings growth, while Citi has also issued a Buy rating. Such recommendations may encourage buying interest in the shares. Wall Street analysts look optimistic on Intuitive Surgical Intuitive Surgical gets a Buy from Citi
• Positive Sentiment: The da Vinci Single-Port platform is gaining momentum. Rising procedure volumes, utilization, placements, expanding indications and international adoption could create another significant recurring-revenue growth engine for Intuitive Surgical. Can ISRG’s Single-Port Platform Become the Next Billion-Dollar Franchise?
• Neutral Sentiment: Investors are focused on the upcoming October 20 earnings report. Results and management’s outlook will be important in determining whether the recent analyst optimism and expected growth are justified. Barclays’ bullish initiation amid rising rivalry
• Negative Sentiment: Competition and valuation remain risks. Commentary points to growing rivalry, particularly from Johnson & Johnson, while ISRG’s premium valuation could limit upside or increase sensitivity to an earnings miss. Intuitive Surgical and JNJ give Jim Cramer more than valuation to consider

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 400 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the sale, the director directly owned 251 shares in the company, valued at $95,129. This represents a 61.44% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Monday, August 10th. The shares were sold at an average price of $379.00, for a total value of $151,600.00. Following the sale, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. The trade was a 6.99% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock worth $4,891,989 over the last three months. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Stock Up 0.4%

NASDAQ:ISRG traded up $1.67 during trading hours on Thursday, hitting $416.19. 839,510 shares of the stock traded hands, compared to its average volume of 2,414,616. The company has a market cap of $147.03 billion, a price-to-earnings ratio of 47.69, a price-to-earnings-growth ratio of 3.05 and a beta of 1.46. The stock has a 50 day moving average price of $383.70 and a 200 day moving average price of $411.61. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts’ consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. During the same quarter in the prior year, the company posted $1.81 earnings per share. The business’s quarterly revenue was up 18.4% compared to the same quarter last year. Equities analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on ISRG shares. Barclays upgraded shares of Intuitive Surgical to a “strong-buy” rating in a report on Wednesday. Bank of America reduced their price target on shares of Intuitive Surgical from $520.00 to $515.00 in a research note on Friday, June 12th. Weiss Ratings reissued a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. Robert W. Baird dropped their target price on shares of Intuitive Surgical from $525.00 to $500.00 and set an “outperform” rating on the stock in a report on Friday, July 17th. Finally, Royal Bank Of Canada cut their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a research report on Monday, July 13th. One analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $502.53.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.